Sanford Biotech sp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-07-20
Share capital
7,700.00 PLN
Average employment (people)
1 (2025)
Activity description

Sanford Biotech is a company that develops stem cell therapies and growth factor treatments for both human and veterinary medicine. It offers advanced biological therapies for companion animals, including innovative treatments for arthritis in dogs and atopic dermatitis in dogs and cats. Additionally, it focuses on therapies for horses and dairy cattle, reflecting a shift in how these animals are perceived and treated in veterinary care.

Registered address
Aleja Marsz. Józefa Piłsudskiego 35/E, 05-077 Warszawa, Poland
Opening hours
Mon–Fri, 9:00–16:00
Email
Phone
Electronic delivery address
AE:PL-49467-72267-BWUFF-18

Financials

Revenue history

From the notes

Profit allocationNo decision
Capital expenditure$42,307
Planned capital expenditure (next year)$25,113
Related parties1 items

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 130 days for 2021).

  • 202514/07/2026
  • 202410/07/2025
  • 202318/07/2024
  • 202218/07/2023
  • 202122/11/2022
  • 202018/11/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 91%
Sector · Manufacturing23,334 / 24,570
Top 95%
City · Warszawa50,599 / 56,772
Top 89%
Voivodeship · Mazowieckie69,539 / 76,953
Top 90%
Country · Poland272,642 / 297,266
Top 92%

Results vs industry

Revenue
This companyUSD 2.59kMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD -15.16kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 13.80kMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 112.13kMedianUSD 897.46kAverageUSD 31.52m

Offer

  • Stem cell therapies
  • Platelet-rich plasma therapy
  • Biological therapies
  • Translational research

Websites

  • sanfordbiotech.comSanford Biotech | komórki macierzyste i badania translacyjne
    Google AnalyticsGoogle Tag ManagerLiteSpeed

Authorized Representatives

Joanna Sanford age 59 – Management Board Member

Manner of representation

In the case of a one-person management board, declarations on behalf of the company are made by the member of the management board. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
154$2,079.96100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2025-08-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Change history

DateEvent
2025-09-17Share capital increase
2025-09-17Switch to PKD 2025
2017-07-20Entered in the register

FAQ

Last updated: 2026-10-07